Jun 2026 (Q2 FY26) — Jul 21, 2026
The Charles Schwab Corporation Q2 FY26 — Record Performance and Strong Client Engagement
Read the full callSchwab Charles (SCHW) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Schwab Charles earnings: last reported Tue, 21 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 7,072 | +20.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 2,800 | +31.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
13 of 14 judged targets kept · 23 open · verdicts reflect calls analysed to Mar 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year adjusted expense growth | 9.5% to 10.5% reported (5.5% to 6.5% underlying) | C2 2026 | New | |
| Spot crypto trading launch | Launch direct spot crypto trading sometime in 2025 | Dec 2024 | the employee pilot is underway, and we expect the phased client rollout will begin in the coming weeks | Missed |
1 of SCHWAB CHARLES CORP's 37 targets was missed. See which ones, and which are quietly gone. The 2 above are the free sample; 35 more targets are in the full ledger.
Claimed
- Delivered record financial results with $7.1 billion in total revenue and adjusted EPS of $1.62, up 42% year-over-year.
- Attracted 1.4 million new brokerage accounts and $120 billion in core net new assets, up nearly 50% over last year.
- Managed investing net flows increased 53% year-over-year, and bank lending balances reached $67 billion, up 33%.
- Adjusted pretax profit margin expanded to 54.3%.
- Daily average trades reached $11.9 million, driving a 28% increase in trading revenue to $1.2 billion.
Qualified
Price
$89.58 −2.59% · −$2.38
Performance −4.8% 1Y
1Y: $94.14 on 17 Oct 2025 → $89.58. High $113.65 (24 Aug 2026), low $85.35 (28 May 2026).
- Previous close
- $91.96
- 52-week range
- $85.35 – $113.65
- One year
- −5.66%
Overview
- Symbol
- SCHW
- Sector
- Financials
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
13 of 14 judged targets kept · 23 open · verdicts reflect calls analysed to Mar 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Full-year adjusted expense growth | 9.5% to 10.5% reported (5.5% to 6.5% underlying) | C2 2026 | New | |
| Spot crypto trading launch | Launch direct spot crypto trading sometime in 2025 | Dec 2024 | the employee pilot is underway, and we expect the phased client rollout will begin in the coming weeks | Missed |
Claimed
- Delivered record financial results with $7.1 billion in total revenue and adjusted EPS of $1.62, up 42% year-over-year.
- Attracted 1.4 million new brokerage accounts and $120 billion in core net new assets, up nearly 50% over last year.
- Managed investing net flows increased 53% year-over-year, and bank lending balances reached $67 billion, up 33%.
- Adjusted pretax profit margin expanded to 54.3%.
- Daily average trades reached $11.9 million, driving a 28% increase in trading revenue to $1.2 billion.
Qualified
The full ledger
Open SCHWAB CHARLES CORP’s full ledger
A free account opens 5 company ledgers a month. All 37 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — Apr 16, 2026
The Charles Schwab Corporation Q1 FY26 — Record Client Growth and Financial Results Driven by Strategic Innovation
Read the full callMar 2025 (Q1 FY25) — Apr 17, 2025
Charles Schwab Q1 FY25 — Strong Growth Across Client Metrics and Financials
Read the full callEvery analysed call
Schwab Charles earnings calls (SCHW)
Financials
What the filings say
Net profit, year on year: +32% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 4,847 | 5,329 | 5,599 | 5,851 | 6,135 | 6,336 | 6,482 | 7,072 |
| Interest | 1,706 | — | — | — | — | — | — | — |
| Profit before tax | 1,842 | 2,305 | 2,455 | 2,803 | 3,021 | 3,180 | 3,188 | 3,669 |
| Tax rate | 23.6% | 20.2% | 22.2% | 24.1% | 21.9% | 22.7% | 22.2% | 23.7% |
| Net profit | 1,408 | 1,840 | 1,909 | 2,126 | 2,358 | 2,459 | 2,479 | 2,800 |
| EPS ($ per share) | 0.71 | — | 0.99 | 1.09 | 1.26 | — | 1.37 | 1.55 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 15 | 15 | 20 | — | — | — | — | — |
| Reserves | 17,329 | 19,960 | 21,975 | 25,992 | 31,066 | 33,901 | 37,568 | 44,065 |
| Total liabilities | 275,812 | 272,260 | 492,949 | 611,009 | 515,164 | 452,220 | 431,468 | 441,570 |
| Fixed assets | 1,769 | 2,128 | 2,883 | 3,442 | 3,714 | 3,690 | 3,338 | 3,091 |
| Total assets | 296,482 | 294,000 | 549,009 | 667,270 | 551,772 | 493,178 | 479,843 | 490,995 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 12,456 | 9,325 | 6,852 | 2,118 | 2,057 | 19,587 | 2,670 | 9,311 |
| Cash from investing | -40,555 | 11,964 | -125,851 | -75,663 | 32,048 | 57,411 | 35,431 | 24,538 |
| Cash from financing | 47,166 | -13,939 | 143,982 | 96,323 | -68,723 | -61,245 | -47,060 | -29,702 |
| Net cash flow | 19,067 | 7,350 | 24,983 | 22,778 | -34,618 | 15,753 | -8,959 | 4,147 |
| Capital expenditure | -570 | -708 | -631 | -916 | -971 | -700 | -620 | -548 |
| Free cash flow | 11,886 | 8,617 | 6,221 | 1,202 | 1,086 | 18,887 | 2,050 | 8,763 |
SCHW revenue by segment
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Investor Services | 78% | 83% | 79% | 79% | 80% | 79% | 78% | 78% | +19.3% |
| Advisor Services | 22% | 17% | 21% | 21% | 20% | 21% | 22% | 22% | +27.0% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Insider filings
185 filings between Oct 23, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
$1.85M
1 purchase by 1 insider
Sales
$334.53M
91 sales by 15 insiders
38% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 18
- Award — granted as compensation
- 42
- Option exercise — converted options into shares
- 11
- Tax withheld — shares kept back by the company to cover tax
Also filed: 22 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Schwab Charles R. | — | $185.84M | Aug 24, 2026 |
| Bettinger Walter W | — | $91.84M | Aug 28, 2026 |
| Craig Jonathan M. | — | $13.85M | Aug 14, 2026 |
| Schwab-Pomerantz Carolyn | — | $13.23M | Aug 26, 2026 |
| Murtagh Nigel J | — | $11.53M | Aug 10, 2026 |
| Howard Dennis | — | $6.79M | Aug 13, 2026 |
| Woolway Paul V | — | $3.66M | Apr 15, 2026 |
| Wurster Richard A | $1.85M | — | May 28, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Hathi Neesha MD, Head Wealth Adv, Bnk, Tst | Sale 10b5-1 plan | 5,000 | $489.0K |
| Oct 1, 2026 | Hathi Neesha MD, Head Wealth Adv, Bnk, Tst | Option exercise 10b5-1 plan | 5,000 | $209.9K |
| Sep 23, 2026 | Ellis Stephen A Director | Option exercise | 1,918 | $60.4K |
| Sep 1, 2026 | Hathi Neesha MD, Head Wealth Adv, Bnk, Tst | Option exercise 10b5-1 plan | 3,177 | $165.4K |
| Sep 1, 2026 | Hathi Neesha MD, Head Wealth Adv, Bnk, Tst | Sale 10b5-1 plan | 3,177 | $346.4K |
| Aug 28, 2026 | Hathi Neesha MD, Head Wealth Adv, Bnk, Tst | Option exercise 10b5-1 plan | 3,177 | $165.4K |
| Aug 28, 2026 | Bettinger Walter W Co-Chairman | Option exercise | 74,388 | $3.48M |
| Aug 28, 2026 | Hathi Neesha MD, Head Wealth Adv, Bnk, Tst | Sale 10b5-1 plan | 3,177 | $343.5K |
| Aug 28, 2026 | Bettinger Walter W Co-Chairman | Sale | 74,388 | $8.25M |
| Aug 27, 2026 | Schwab Charles R. Co-Chairman | Gift | 9,300 | $0 |
| Aug 26, 2026 | Schwab-Pomerantz Carolyn Director | Sale | 9,175 | $1.00M |
| Aug 24, 2026 | Bettinger Walter W Co-Chairman | Option exercise | 176,210 | $8.25M |
| Aug 24, 2026 | Bettinger Walter W Co-Chairman | Sale | 176,210 | $20.00M |
| Aug 24, 2026 | Schwab Charles R. Co-Chairman | Sale | 117,000 | $13.24M |
| Aug 18, 2026 | Schwab Charles R. Co-Chairman | Gift | 54,550 | $0 |
| Aug 17, 2026 | Schwab Charles R. Co-Chairman | Gift | 45,500 | $0 |
| Aug 17, 2026 | Beatty Jonathan S MD, Head of Advisor Services | Sale | 1,000 | $111.3K |
| Aug 14, 2026 | Craig Jonathan M. MD, Head of Retail Investing | Option exercise 10b5-1 plan | 21,866 | $1.02M |
| Aug 14, 2026 | Craig Jonathan M. MD, Head of Retail Investing | Sale 10b5-1 plan | 21,866 | $2.43M |
| Aug 13, 2026 | Howard Dennis MD, Chief Tech, OPS & Data Off | Sale 10b5-1 plan | 2,198 | $241.8K |
| Aug 12, 2026 | Schwab Charles R. Co-Chairman | Sale | 46,410 | $5.02M |
| Aug 11, 2026 | Schwab Charles R. Co-Chairman | Sale | 46,445 | $5.01M |
| Aug 10, 2026 | Murtagh Nigel J Chief Risk Officer | Sale 10b5-1 plan | 24,778 | $2.70M |
| Aug 10, 2026 | Murtagh Nigel J Chief Risk Officer | Option exercise 10b5-1 plan | 24,778 | $1.16M |
| Aug 7, 2026 | SNEED PAULA A Director | Sale | 5,263 | $564.0K |
| Aug 6, 2026 | Murtagh Nigel J Chief Risk Officer | Sale 10b5-1 plan | 1,897 | $206.8K |
| Aug 6, 2026 | Murtagh Nigel J Chief Risk Officer | Option exercise 10b5-1 plan | 1,897 | $88.8K |
| Aug 6, 2026 | Schwab Charles R. Co-Chairman | Gift | 37,200 | $0 |
| Aug 5, 2026 | Craig Jonathan M. MD, Head of Retail Investing | Sale 10b5-1 plan | 21,750 | $2.33M |
| Aug 5, 2026 | Craig Jonathan M. MD, Head of Retail Investing | Option exercise 10b5-1 plan | 21,750 | $1.02M |
| Aug 5, 2026 | Schwab-Pomerantz Carolyn Director | Sale | 18,561 | $2.00M |
| Aug 4, 2026 | Schwab-Pomerantz Carolyn Director | Sale | 22,640 | $2.41M |
| Aug 4, 2026 | Schwab Charles R. Co-Chairman | Sale | 47,650 | $5.05M |
| Aug 3, 2026 | Schwab Charles R. Co-Chairman | Sale | 95,250 | $10.05M |
| Aug 1, 2026 | Howard Dennis MD, Chief Tech, OPS & Data Off | Tax withheld | 1,292 | $135.5K |
| Jul 29, 2026 | Schwab Charles R. Co-Chairman | Sale | 95,450 | $10.10M |
| Jul 28, 2026 | Schwab-Pomerantz Carolyn Director | Gift | 271 | $0 |
| Jul 28, 2026 | Schwab-Pomerantz Carolyn Director | Sale | 22,650 | $2.39M |
| Jul 28, 2026 | Howard Dennis MD, Chief Tech, OPS & Data Off | Sale 10b5-1 plan | 28,000 | $2.94M |
| Jul 28, 2026 | Howard Dennis MD, Chief Tech, OPS & Data Off | Option exercise 10b5-1 plan | 28,000 | $1.79M |
| Jul 28, 2026 | Schwab Charles R. Co-Chairman | Gift | 60,000 | $0 |
| Jul 28, 2026 | Schwab Charles R. Co-Chairman | Sale | 48,000 | $5.07M |
| Jul 28, 2026 | Bettinger Walter W Co-Chairman | Sale | 38,263 | $4.02M |
| Jul 28, 2026 | Bettinger Walter W Co-Chairman | Option exercise | 93,408 | $4.86M |
| Jul 28, 2026 | Bettinger Walter W Co-Chairman | Sale | 12,880 | $1.36M |
| Jul 28, 2026 | Bettinger Walter W Co-Chairman | Sale | 42,265 | $4.39M |
| Jul 27, 2026 | Murtagh Nigel J Chief Risk Officer | Sale 10b5-1 plan | 11,000 | $1.14M |
| Jul 27, 2026 | Bettinger Walter W Co-Chairman | Sale | 192,488 | $20.00M |
| Jul 27, 2026 | Bettinger Walter W Co-Chairman | Option exercise | 192,488 | $10.02M |
| Jul 27, 2026 | Murtagh Nigel J Chief Risk Officer | Sale 10b5-1 plan | 21,947 | $2.28M |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for SCHWAB CHARLES CORP
Free account. Everything above stays public.
Write why you follow SCHWAB CHARLES CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other companies in Financials
Nearest to Schwab Charles by market cap among the sector's top 20 companies at Q2 2026.